Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Advertise in Pharma in Focus

Advertising in Pharma in Focus delivers you:

  • Unique access to a $17 billion industry
  • High visibility with over 11,500 readers every working day
  • Great reaction with high click through rates
  • Unparalled contact via unique beyond-the-click services

For more information, ring 02 9938 4381

Pressure builds for policy change
NMP stretched at the seams as cries for change grow louder.
Approvals Action
New form for threatened epilepsy drug
UCB adds dose as older version faces generics.
Special Report
PBAC July outcomes in full
Major recs and rejects evenly split.
Pipeline Monitor
Novartis moves on allergies
PBS asthma therapy looks at allergy expansion.